رفتن به محتوا

Cannabinoids- Introduction – Drugs of AbuseCannabinoids- Introduction – Drugs of Abuse

Drug Schedules and Controlled Substances – Drugs of Abuse

Harm of Each Drug Type – Drugs of Abuse

Caffeine and Nicotine – Drugs of Abuse

Amphetamines – Drugs of Abuse

Cocaine – Drugs of Abuse

Alcohols – Drugs of Abuse

Opioid Analgesics – Drugs of Abuse

Sedative_Hypnotic Drugs- Benzodiazepines, Barbiturates and Ethanol – Drugs of Abuse

Inhalants- Anesthetics, Industrial Solvents and Organic Nitrates – Drugs of Abuse

Hallucinogens- Psychodelics, Dissociatives and Deliriants – Drugs of Abuse

Cannabinoids- THC and CBD – Drugs of Abuse

Cannabinoids- Methods of Ingestion – Drugs of Abuse

Effects of Unrefined Marijuana – Drugs of Abuse

Cannabinoids- Consumption and Hyperemesis Syndrome – Drugs of Abuse

Guidelines for Cannabinoid Use – Drugs of Abuse

Cannabinoids- Summary – Drugs of Abuse

Acetaminophen and Steroids – Drugs of Abuse

Drugs in Hypertension

Introduction to High Blood Pressure Medication – Drugs in Hypertension

Lines of Therapy – Drugs in Hypertension

Sympathetic Blockers

Sympathomimetic Activators

Sympathomimetic Effects

Alpha Agonists – Drugs in Hypertension

Alpha- and Beta-Blockers

Beta Blockers – Drugs in Hypertension

Postganglionic Sympathetic Nerve Terminal Blockers and Monoamine Oxidase Inhibitors – Drugs in Hypertension

Diuretics – Drugs in Hypertension

Vasodilators – Drugs in Hypertension

Renin Angiotensin Aldosterone – Drugs in Hypertension

Pulmonary Hypertension Medication – Drugs in Hypertension

Questions and Case Studies – Drugs in Hypertension

Heart Failure and Angina Management

Introduction – Heart Failure and Angina Management

Inotropes – Heart Failure and Angina Management

Cardiac Depressants and Vasodilators – Heart Failure and Angina Management

Nitrates – Heart Failure and Angina Management

Vasodilators – Heart Failure and Angina Management

Renin-Angiotensin Agents and Beta Blockers – Heart Failure and Angina Management

Metabolic Modifiers and Slow Sodium Channel Inhibitors – Heart Failure and Angina Management

Slow Sodium Channel and Neprilysin Inhibitors – Heart Failure and Angina Management

Global Effect of Sympathomimetic Drugs on the Vascular System

Questions – Heart Failure and Angina Management

Antiviral Drugs

Anti-Herpes Agents- Thymidine Kinase Agents – Antiviral Drugs

Overview of Antiviral Activity – Antiviral Drugs

Anti-Herpes Agents- RNA Polymerase Inhibitors and Other Drugs – Antiviral Drugs

Overview – Antiviral Agents and Treatment of CMV Retinitis – Antiviral Drugs

Anti-HIV Agents – Antiviral Drugs

Anti-HIV Agents- Entry Inhibitors – Antiviral Drugs

CCR5 – Antiviral Drugs

Anti-HIV Agents- Nucleoside Reverse Transcriptase Inhibitors (NsRTIs) – Antiviral Drugs

Anti-HIV Agents- Nucleotide Reverse Transcriptase Inhibitors (NtRTIs) – Antiviral Drugs

Anti-HIV Agents- Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) – Antiviral Drugs

Anti-HIV Agents- Integrase Strand Transfer Inhibitors – Antiviral Drugs

Anti-HIV Agents- Protease Inhibitors – Antiviral Drugs

Anti-HIV Agents- Maturation Inhibitors – Antiviral Drugs

Anti-HIV Agents- Other Inhibitors – Antiviral Drugs

Hepatitis Treatment – Antiviral Drugs

Influenza Treatment – Antiviral Drugs

Case Study – Antiviral Drugs

Case Studies about Anti-HIV Agents – Antiviral Drugs

Antibacterial Agents (Antibiotics)

Overview – Cell Wall Synthesis Inhibitors (Antibiotics)

Penicillins – Cell Wall Synthesis Inhibitors (Antibiotics)

Cephalosporins – Cell Wall Synthesis Inhibitors (Antibiotics)

Penems – Cell Wall Synthesis Inhibitors (Antibiotics)

Monobactams, Cyclic Lipopeptide and Polypeptide – Cell Wall Synthesis Inhibitors (Antibiotics)

Glycopeptide and Intracellular Agents – Cell Wall Synthesis Inhibitors (Antibiotics)

Overview – Bacterial Protein Synthesis Inhibitors (Antibiotics)

Aminoglycosides – Bacterial Protein Synthesis Inhibitors (Antibiotics)

Tetracyclines – Bacterial Protein Synthesis Inhibitors (Antibiotics)

Macrolides and Ketolides – Bacterial Protein Synthesis Inhibitors (Antibiotics)

Linezolid, Streptogramins and Chloramphenicol – Bacterial Protein Synthesis Inhibitors (Antibiotics)

Sulfonamides, Trimethoprim and Fluoroquinolones – Antimetabolites

Overview – Antimetabolites

Case Studies – Antimetabolites

Quiz Questions and Case Studies – Antibacterial Agents (Antibiotics)

Overview – Antifungals

Polyenes – Antifungals

Azoles – Antifungals

Echinocandins – Antifungals

Flucytosine (5-Fluorocytosine_5-FC) – Antifungals

Griseofulvin and Squalene Epoxidase Inhibitor (Terbinafine) – Antifungals

Questions – Antifungals

Antiprotozoal & Anthelmintic Drugs

Amebicides – Antiprotozoal Agents

Antimalarial Drugs – Antiprotozoal Agents

Nematicides – Anthelmintic Drugs

Trematocides (Praziquantel) and Cestodicides (Niclosamide) – Anthelmintic Drugs

Questions – Antiprotozoal and Anthelmintic Drugs

Antimycobacterial Agents

Overview – Antimycobacterial Agents

First-line Agents to Treat Tuberculosis – Antimycobacterial Agents

New Agents to Treat Tuberculosis – Antimycobacterial Agents

Other Agents to Treat Tuberculosis – Antimycobacterial Agents

Treatment Regimens for Mycobacterium Tuberculosis – Antimycobacterial Agents

Treatment Regimens for Leprosy and Other Infections – Antimycobacterial Agents

Case Studies – Antimycobacterial Agents

Pharmacokinetics (PK)

Introduction to Kinetics – Pharmacokinetics (PK)

Phases of Drug Development – Absorption and Distribution – Pharmacokinetics (PK)

Drug Distribution – Absorption and Distribution – Pharmacokinetics (PK)

Hydrophilic vs. Hydrophobic – Absorption and Distribution – Pharmacokinetics (PK)

pKa and Drug Solubility – Absorption and Distribution – Pharmacokinetics (PK)

Drug Metabolism – Biotransformation – Pharmacokinetics (PK)

Factors Affecting Drug Metabolism – Biotransformation – Pharmacokinetics (PK)

Elimination Kinetics

Introduction esp. Types of Eliminations – Elimination Kinetics

First Pass Metabolism – Elimination Kinetics

Intravenous vs. Oral Medications – Elimination Kinetics

Bioavailability incl. Case Study – Elimination Kinetics

Dosage Calculation- Maintenance Dose and Loading Dose – Elimination Kinetics

Renal Clearance – Elimination Kinetics

Case Study- Correction for Renal Disease

Pharmacodynamics

Introduction and Definitions of Pharmacodynamics – Pharmacodynamics

Drug Receptors and Effectors – Pharmacodynamics

Dose-Response, Binding, Quantal, Toxicity & Potency Curves – Pharmacodynamics

Upregulation and Downregulation – Pharmacodynamics

Cardiovascular Pharmacology – Arrhythmias

Introduction – Antiarrhythmic Drugs

Group 1- Sodium Channel Blockers – Antiarrhythmic Drugs

Group 2- Beta Blockers – Antiarrhythmic Drugs

Group 3- Potassium Channel Blockers – Antiarrhythmic Drugs

Group 4- Calcium Channel Blockers – Antiarrhythmic Drugs

Group 5- Other Antiarrhythmics – Antiarrhythmic Drugs

Questions – Antiarrhythmic Drugs

Reproductive Pharmacology

Overview – Reproductive Pharmacology

Estrogens and Progestins – Reproductive Pharmacology

Anti-Estrogens and Antiprogestins – Reproductive Pharmacology

Androgens and Antiandrogens

Questions and Case Studies – Reproductive Pharmacology

Gastrointestinal Drugs

Stomach Ulcer (Peptic Acid Disease) Medication

Nausea Medication- Antiemetics – Gastrointestinal Drugs

Pancreatic Enzyme Replacement Therapy (PERT) and Gallstone Prevention – Gastrointestinal Drugs

Inflammatory Bowel Disease Medication

Irritable Bowel Syndrome (IBS) Medication

Motility Disorder Medication

Questions and Case Studies- H2 Blockers, GERD Medication and Domperidone

Questions and Case Studies- Steroids, Cyclosporine and Crohn’s Disease

Asbestos, PCB’s, Herbicides & Pesticides – Toxic Substances

Carbon Monoxide and Dioxins – Toxic Substances

Toxicology Questions & Case Studies

Autonomic Nervous System & Cholinergic Drugs

Autonomic Nervous System (ANS)- Overview

Dual Innervation

Cholinomimetic Activators and Effects

Cholinergic Toxicity, Myasthenic Crisis and Cholinergic Crisis

Anticholinergic Drugs

Topical Medications

Types of Topical Medications

Stable Phase Mixtures – Topical Medications

Unstable Phase Mixtures – Topcial Medications

Questions – Lipid Control

Bile Acid Sequestrants, Niacin and Fibrates – Lipid Control

Fat Absorption and MTP Inhibitors – Lipid Control

HMG-CoA Reductase Inhibitors – Lipid Control

PCSK9 Inhibitors – Lipid Control

موضوع قبلی

موضوع بعدی

Antimycobacterial Agents

pharma
Antimycobacterial Agents

برای مشاهده این ویدیو باید اشتراک فعال داشته باشید

خرید اشتراک

محتوای بخش

Overview – Antimycobacterial Agents

First-line Agents to Treat Tuberculosis – Antimycobacterial Agents

New Agents to Treat Tuberculosis – Antimycobacterial Agents

Other Agents to Treat Tuberculosis – Antimycobacterial Agents

Treatment Regimens for Mycobacterium Tuberculosis – Antimycobacterial Agents

Treatment Regimens for Leprosy and Other Infections – Antimycobacterial Agents

Case Studies – Antimycobacterial Agents

قبلی موضوع قبلی

بعدی موضوع بعدی

بازگشت به دوره